mannitol has been researched along with Cytomegalovirus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henshaw, J; Mossop, B; Yuan, F | 1 |
| Boersma-van Ek, W; de Maar, EF; Kleibeuker, JH; The, TH; van Son, WJ | 1 |
| Batard, P; Cerottini, JC; Guillaume, P; Liénard, D; Pittet, MJ; Rimoldi, D; Romero, P; Speiser, DE | 1 |
3 other study(ies) available for mannitol and Cytomegalovirus
| Article | Year |
|---|---|
Enhancement of electric field-mediated gene delivery through pretreatment of tumors with a hyperosmotic mannitol solution.
Topics: Animals; Cell Line, Tumor; Cell Membrane; Cytomegalovirus; Electrophoresis; Electroporation; Female; Gene Transfer Techniques; Luciferases, Firefly; Mannitol; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Promoter Regions, Genetic | 2011 |
Increased intestinal permeability during cytomegalovirus infection in renal transplant recipients.
Topics: Adolescent; Adult; Aged; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Intestinal Diseases; Intestines; Kidney Transplantation; Lactulose; Male; Mannitol; Middle Aged | 1996 |
In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells.
Topics: Adjuvants, Immunologic; Antigens, Neoplasm; Antigens, Viral; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Differentiation; Cytomegalovirus; HLA-A2 Antigen; HLA-DR Antigens; Humans; Immunologic Memory; Immunotherapy; Influenza A virus; Lymphocyte Activation; Mannitol; MART-1 Antigen; Melanoma; Neoplasm Proteins; Oleic Acids; Peptide Fragments; Vaccines, Subunit; Viral Matrix Proteins | 2002 |